Four mouse monoclonal antibodies were developed after immunization with one human immunodeficiency
309), but no HIV-1 isolates. Two anti-matrix (p16) antibodies, named R5C4 and R5F6, reacted strongly only with the HIV-2 isolates. The use of these monoclonal antibodies for rapid discrimination and identification of acquired immunodeficiency syndrome-related retroviruses is discussed.
A group of recently discovered retroviruses share many structural, biological, genetic, and antigenic properties with the human immunodeficiency virus (HIV) type 1, the etiological agent of the acquired immunodeficiency syndrome (AIDS) (1, 2) . This group includes isolates from several primate species referred to as simian immunodeficiency virus (SIV) and isolates from healthy West African individuals and patients with immunodeficiency referred to as HIV-2 (3) (4) (5) (6) . Nucleic acid sequence analysis of HIV-1, HIV-2, and SIV has revealed that HIV-2 and SIV are more closely related to each other than to HIV-1 (7) (8) (9) . In fact, there is only 42% overall sequence identity between the HIV-1 and HIV-2 genomes (10) . Both SIV and HIV-2 display serological cross-reactivity with HIV-1 that is limited to the gag and pol viral proteins (3) (4) (5) (6) . Most importantly, there are significant differences in pathogenicity among these retroviruses. This presents a very complex epidemiological situation, particularly in Africa. To understand the mode of transmission and pathogenicity of these retroviruses, it is essential to develop specific reagents that make possible their rapid identification.
Here we report the development of four monoclonal antibodies (mAbs) directed against epitopes of capsid (CA) and matrix (MA) proteins (11) of HIV-2 and describe their reactivities with different isolates of HIV-1, HIV-2, and SIV.
One of these antibodies reacts with an epitope of the CA protein of HIV-2 that is present in all HIV-1, HIV-2, and SIV isolates tested thus far. The other three antibodies react with less conserved epitopes of HIV-2 core proteins and may prove useful in discriminating among various HIV-1, HIV-2, and SIV isolates.
MATERIALS AND METHODS
Cells and Viruses. Viruses were propagated in the human T-cell line HUT-78 or in the H9 clone. The HIV-1 isolates [human T-cell leukemia/lymphoma virus (HTLV)-IIIB, HTLV-IIIMN, HTLV-IIIc, HTLV-IIIRF, and HTLV11IRutzI have been previously described (1, 12) . The HIV-2 strain used for immunization was isolated from the peripheral blood lymphocytes of an AIDS patient and was designated HIV-2NIHz (13) . This isolate is serologically very similar to the LAV-2Rd isolate previously described (6) tTo whom reprint requests should be addressed.
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for specific antibody production by the immunofluorescence technique described below. Hybridomas secreting antibodies reactive against HIV-2 were subcloned by limiting dilution. Cells were plated at a concentration of 0.5 cell per well in round bottom 96-well microplates. To increase plating efficiency of these cells, conditioned culture fluids harvested from Sp2 cells were included in the hypoxanthine/aminopterin/thymidine culture medium.
Immunofluorescence and Other Immunological Assays. The indirect immunofluorescence assay was carried out on fixed cells as described (17) . Briefly, uninfected and infected HUT-78 and H9 cells were spotted on slides, air-dried, and fixed for 10 min in acetone/methanol, 1:1 (vol/vol). Supernatant (10 pl) to be tested was applied and incubated 30 min at room temperature. Fluorescein-conjugated goat antimouse immunoglobulin (IgA, IgM, and IgG) (Cappel Laboratories, Cochranville, PA) was the second antibody. In some cases, hybridoma supernatants were tested for specific anti-HIV-2 antibodies by using a spot-immunofluorescence technique (A.A.M., unpublished results). Class and subclass determinations of immunoglobulins secreted by hybridomas were performed by using the Ouchterlony technique with specific anti-mouse immunoglobulin typing sera (Calbiochem). For detection of HIV-1 core proteins, two previously described mAbs, designated BT3 and M33, were used (18) .
Immunological Blot Assay. Viral proteins were separated from sucrose gradient-banded HIV-1, HIV-2, and SIV by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and were blotted onto a nitrocellulose sheet according to Towbin et al. (19) . The blots were reacted with each mAb as well as with HIV-1 and HIV-2 positive and negative control human sera as described elsewhere (20) .
RESULTS
Development and Characterization of mAbs. Out of 118 individual hybridomas that grew in hypoxanthine/aminopterin/thymidine medium, 48 secreted antibodies reactive with HIV-2NIHZ-infected HUT-78 cells. However, 44 of these also reacted with uninfected HUT-78 cells, which clearly demonstrated that the antigen used for immunization contained material originating from the cells that were used for propagation of the virus. Four hybridomas reacted with HIV-2NIH-z-infected HUT-78 cells but lacked reactivity with uninfected HUT-78 cells and were, therefore, considered virus-specific. These hybridomas were cloned twice and were designated R1C7, A4F6, R5C4, and RSF6. They continue to secrete specific antibodies 3 months after fusion. All four are of the IgGI-subclass as determined by the Ouchterlony technique by using class-and subclass-specific antimouse immunoglobin typing antisera. (Fig. 1) . The data from an extensive survey of immunofluorescence reactivities with various isolates are summarized in Table 1 Proc. Natl. Acad Sci. USA 85 (1988) 
Reactivity
The M33 and BT3 mAbs are directed against HIV-1 core proteins; the remaining mAbs are anti-HIV-2NIH-z antibodies.
The identification of HIV-2 proteins reacting with mAbs is described in Fig. 2 (Fig. 2) . All four mAbs reacted with the gag proteins of HIV-2. Whereas antibodies R5C4 and R5F6 reacted with the MA (p16) protein of HIV-2 ( Fig. 2A, lanes 1 and 2) , A4F6 and R1C7 reacted specifically with the CA protein (p24) of HIV-2 ( Fig. 2A, lanes 3 and 4) .
All four mAbs reacted with a gag precursor protein p55 of HIV-2, which is sometimes packaged in the virion. The cross-reactivity found with immunofluorescence was confirmed by immunological blot analysis. Antibody R1C7, which is specific for CA of HIV-2, also reacted with the CA proteins of HIV-1 and SIV ( Fig. 2 B and C, lane 4) . A4F6 reacted with p24 of HIV-2 and SIV (STLV-IIIAGM), whereas R5C4 and R5F6, which are specific for the MA protein of HIV-2, did not cross-react with HIV-1 or SIV. Again, all the mAbs recognizing the gag proteins reacted with the precursor p55.
DISCUSSION
Four mouse mAbs were developed after immunization with the HIV-2NIH-z isolate and were tested for reactivity with different HIV-1, HIV-2, and SIV isolates in an indirect immunofluorescence assay. One of them, R1C7, consistently reacted with all HIV-1, HIV-2, and SIV isolates tested so far, indicating that this particular epitope is highly conserved. By using immunological blot analysis, the epitope reacting with the R1C7 mAb was assigned to the CA protein of these immunodeficiency retroviruses. This is in line with previous observations showing serological cross-reactivity between HIV-1, HIV-2, and SIV core proteins (3-6).
Given its broad reactivity, the R1C7 mAb can be used for detection of members of the AIDS-related retrovirus family in tissues, body fluids, or cultured cells. Also, it may prove Immunology: Minassian et al.
useful for assessing the level of p24 antigenemia, which has been shown to be an early sign of HIV infection (21, 22 (25) (26) (27) (29) . In West Africa, the number of AIDS cases is relatively low in spite of the fact that a considerable number of healthy HIV-2 seropositive individuals has been identified (23, 30) . In the case of SIV, there are very limited data available regarding the pathogenicity of these viruses in their natural hosts. However, it is well established that some SIV isolates cause immunodeficiency in rhesus macaques and sooty mangabeys infected in captivity (3) (4) (5) 14 
